GH Research to Attend Neuropsychopharmacology Meeting
Ticker: GHRS · Form: 6-K · Filed: Dec 5, 2024 · CIK: 1855129
Sentiment: neutral
Topics: conference-attendance, company-update
TL;DR
GH Research is going to a big pharma conference Dec 8-11. Expect news.
AI Summary
GH Research PLC announced on December 5, 2024, that it will participate in the 63rd Annual Meeting of the American College of Neuropsychopharmacology 2024. The meeting is scheduled to occur from December 8 to December 11, 2024.
Why It Matters
GH Research's participation in this key industry event signals potential for updates on their research and development pipeline in the neuropsychopharmacology field.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in an industry conference and does not contain material financial or operational changes.
Key Players & Entities
- GH Research PLC (company) — Registrant
- American College of Neuropsychopharmacology (company) — Conference Host
- December 8 - 11, 2024 (date) — Conference Dates
- December 5, 2024 (date) — Filing Date
FAQ
What is the purpose of GH Research PLC's filing on December 5, 2024?
The purpose of the filing is to report that GH Research PLC will attend the 63rd Annual Meeting of the American College of Neuropsychopharmacology 2024.
When is the 63rd Annual Meeting of the American College of Neuropsychopharmacology scheduled to take place?
The meeting is scheduled to take place from December 8 to December 11, 2024.
What is the Commission File Number for GH Research PLC?
The Commission File Number for GH Research PLC is 001-40530.
Where is GH Research PLC's principal executive office located?
GH Research PLC's principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
Does GH Research PLC file annual reports under Form 20-F or Form 40-F?
GH Research PLC files annual reports under cover of Form 20-F.
Filing Stats: 179 words · 1 min read · ~1 pages · Grade level 15.2 · Accepted 2024-12-05 07:00:39
Filing Documents
- ef20039508_6k.htm (6-K) — 8KB
- 0001140361-24-048431.txt ( ) — 9KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2024. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K GH Research PLC will attend the 63 rd Annual Meeting of the American College of Neuropsychopharmacology 2024, which is scheduled to take place from December 8 - 11, 2024. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: December 5, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 2